Breaking News Instant updates and real-time market news.

ABT

Abbott

$69.05

0.25 (0.36%)

16:15
09/23/18
09/23
16:15
09/23/18
16:15

Abbott announces positive clinical study results from MitraClip trial

Abbott announced positive clinical study results from a randomized controlled trial comparing treatment with the MitraClip device to guideline-directed medical therapy in select patients with secondary mitral regurgitation, or a leaky heart valve, as a result of advanced heart failure. The landmark COAPT study met both the primary safety and efficacy endpoints and all secondary endpoints, and showed treatment with MitraClip plus medical therapy was superior to medical therapy alone in reducing rates of heart failure hospitalizations and improving survival at two years. This therapeutic mitral valve intervention is the first and only to demonstrate positive outcomes in a clinical trial for ailing heart failure patients with clinically significant secondary mitral regurgitation. The COAPT study data will be submitted to the U.S. Food and Drug Administration to support consideration of an expanded indication for Abbott's MitraClip to treat secondary mitral regurgitation. Treatment with MitraClip plus medical therapy resulted in a statistically significant reduction in heart failure hospitalization through two years compared to medical therapy alone. MitraClip treatment reduced all-cause mortality through two years, from 46.1% of patients in the control group to 29.1% in the device group at two years of follow-up. At one year, freedom from device-related complications was 96.6%, exceeding the performance goal for the primary safety endpoint. Patients in the device group experienced significant reduction in MR severity and NYHA class. Treatment with MitraClip provided a substantial improvement in patients' perception of their health status, measured by the KCCQ quality-of-life score, and functional capacity at one year. MitraClip treatment resulted in a reduction in the composite of death or first heart failure hospitalization by 43.0%. The results were consistent across numerous subgroups, including patients with ischemic and non-ischemic cardiomyopathy - a disease of the heart muscle that weakens the ability of the heart to pump blood to the rest of the body - and those at high and low surgical risk.

  • 17

    Oct

ABT Abbott
$69.05

0.25 (0.36%)

08/07/18
NEED
08/07/18
NO CHANGE
Target $74
NEED
Buy
Surmodics price target raised to $74 from $55 at Needham
Needham analyst Mike Matson raised his price target on Surmodics (SRDX) to $74 and kept his Buy rating after its Q3 earnings beat and raised FY18 outlook. The analyst anticipates accelerating revenue growth with more upside to consensus estimates coming from the company's new products such as the .014'' and .018" balloon dilation catheters and Telemark microcatheter, along with its deferred revenue associated with the Abbott (ABT) agreement milestones.
09/05/18
PIPR
09/05/18
NO CHANGE
Target $150
PIPR
Overweight
Piper says investors need exposure to CGM market, prefers DexCom
The strong growth of the continuous glucose monitoring market seen in Q2 will continue for the next several years as CGM pushes towards standard of care in Type 1 diabetes and shows healthy adoption from insulin using Type 2s, Piper Jaffray analyst JP McKim tells investors in a research note. For mass adoption, pricing will need to come down, but even at $3-$4 per day in developed markets CGM is still an $80B worldwide addressable market, the analyst says. He thinks investors "need to have exposure" to the CGM market, and DexCom (DXCM) remains his favorite way to play the space. McKim keeps an Overweight rating on the shares with a $150 price target. He points out that Abbott (ABT), Dexcom and even Medtronic (MDT) posted CGM numbers in Q2 that were much better than expected.
09/10/18
ADAM
09/10/18
NO CHANGE
Target $80
ADAM
Buy
Quidel could draw interest from a larger company, says Canaccord
Canaccord analyst Mark Massaro remains positive on Quidel (QDEL) after hosting meetings with management. The analyst cited rising demand for its new products and he expects the company to continue to take market share from larger companies Alere (ABT) and Becton Dickinson (BDX). He also believes the company could draw interest from a larger company, like the bid Alere got from Abbott. Massaro reiterated his Buy rating and raised his price target to $80 from $78 on Quidel shares.
09/18/18
PIPR
09/18/18
NO CHANGE
Target $150
PIPR
Overweight
DexCom supply constraints getting better, says Piper Jaffray
Piper Jaffray analyst JP McKim says his latest channel checks on DexCom (DXCM) show that supply is still constrained but getting better. Further, the checks indicate that Abbott's (ABT) Libre 14 day sensor is the same price as the 10 day on a per day basis and should be launching in the next month, McKim tells investors in a research note. While it is "too soon to blow the all clear horn" on DexCom's supply issues, things are "improving steadily" and the demand for the company's G6 remains robust, the analyst contends. He believes the continuous glucose monitoring market is "really taking off" and expects continued strong results from DexCom in both Q3 and Q4. McKim keeps an Overweight rating on the shares with a $150 price target.

TODAY'S FREE FLY STORIES

FLIR

Flir Systems

13:08
02/20/19
02/20
13:08
02/20/19
13:08
Recommendations
Flir Systems analyst commentary  »

Flir Systems price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Mar

  • 12

    Mar

  • 13

    Mar

HBM

Hudbay Minerals

$6.77

0.415 (6.54%)

13:08
02/20/19
02/20
13:08
02/20/19
13:08
Downgrade
Hudbay Minerals rating change  »

Canaccord downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

CHTR

Charter

$349.25

0.96 (0.28%)

13:02
02/20/19
02/20
13:02
02/20/19
13:02
Hot Stocks
Charter to launch OTT video service Spectrum TV Essentials »

Charter Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 11

    Mar

KMI

Kinder Morgan

$19.21

0.06 (0.31%)

, ADM

Archer Daniels

$42.00

0.13 (0.31%)

13:01
02/20/19
02/20
13:01
02/20/19
13:01
Periodicals
Kinder Morgan aims to expand Chicago ethanol terminal capacity, Reuters says »

Kinder Morgan (KMI) plans…

KMI

Kinder Morgan

$19.21

0.06 (0.31%)

ADM

Archer Daniels

$42.00

0.13 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 28

    May

HBM

Hudbay Minerals

$6.81

0.46 (7.24%)

13:00
02/20/19
02/20
13:00
02/20/19
13:00
Downgrade
Hudbay Minerals rating change  »

Hudbay Minerals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

SPY

SPDR S&P 500 ETF Trust

$277.81

-0.08 (-0.03%)

, SPX

S&P 500

$0.00

(0.00%)

12:59
02/20/19
02/20
12:59
02/20/19
12:59
Periodicals
China newspaper warns U.S. tariffs may be 'catastrophic' to markets, FBN says »

According to Megan…

SPY

SPDR S&P 500 ETF Trust

$277.81

-0.08 (-0.03%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRL

Hormel Foods

$42.90

-0.41 (-0.95%)

, NEM

Newmont Mining

$35.44

0.9 (2.61%)

12:57
02/20/19
02/20
12:57
02/20/19
12:57
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

HRL

Hormel Foods

$42.90

-0.41 (-0.95%)

NEM

Newmont Mining

$35.44

0.9 (2.61%)

DPZ

Domino's Pizza

$278.73

-0.71 (-0.25%)

NCLH

Norwegian Cruise Line

$53.53

0.14 (0.26%)

BG

Bunge

$53.11

0.44 (0.84%)

WEN

Wendy's

$17.84

-0.05 (-0.28%)

SFM

Sprouts Farmers Market

$24.39

-0.5 (-2.01%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 26

    Feb

  • 27

    Feb

  • 03

    Mar

  • 03

    Mar

  • 06

    Mar

  • 14

    Mar

  • 28

    May

ET

Energy Transfer LP

$15.51

-0.13 (-0.83%)

, A

Agilent

$78.07

0.59 (0.76%)

12:57
02/20/19
02/20
12:57
02/20/19
12:57
Earnings
Notable companies reporting after market close »

Notable companies…

ET

Energy Transfer LP

$15.51

-0.13 (-0.83%)

A

Agilent

$78.07

0.59 (0.76%)

ES

Eversource

$70.36

-0.05 (-0.07%)

SNPS

Synopsys

$103.00

1.1 (1.08%)

CPRT

Copart

$52.20

-1.12 (-2.10%)

GDDY

GoDaddy

$71.63

-1.06 (-1.46%)

FTI

TechnipFMC

$24.71

0.76 (3.17%)

ALB

Albemarle

$83.37

0.245 (0.29%)

WPX

WPX Energy

$13.26

0.02 (0.15%)

CAR

Avis Budget

$29.31

-0.27 (-0.91%)

CAKE

Cheesecake Factory

$46.26

-0.23 (-0.49%)

JACK

Jack in the Box

$79.18

-1.77 (-2.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 25

    Feb

  • 25

    Feb

  • 25

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 01

    Mar

  • 03

    Mar

  • 03

    Mar

  • 04

    Mar

  • 05

    Mar

  • 06

    Mar

  • 06

    Mar

  • 08

    Mar

  • 14

    Mar

  • 17

    Mar

  • 20

    Mar

  • 21

    Mar

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

UNH

UnitedHealth

$269.44

-0.82 (-0.30%)

, ANTM

Anthem

$312.20

0.5 (0.16%)

12:49
02/20/19
02/20
12:49
02/20/19
12:49
Recommendations
Magellan Health buyout 'reasonable' up to $90 per share, says SVB Leerink »

SVB Leerink analyst Ana…

UNH

UnitedHealth

$269.44

-0.82 (-0.30%)

ANTM

Anthem

$312.20

0.5 (0.16%)

CNC

Centene

$65.13

0.725 (1.13%)

MGLN

Magellan Health

$70.85

5.8 (8.92%)

WCG

WellCare

$278.49

1.42 (0.51%)

HUM

Humana

$308.33

2.98 (0.98%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

  • 07

    Mar

  • 12

    Mar

  • 19

    Mar

  • 28

    May

XEL

Xcel Energy

$53.90

0.12 (0.22%)

12:45
02/20/19
02/20
12:45
02/20/19
12:45
Hot Stocks
Xcel Energy increases dividend to 40.5c from 38c per share »

The board of directors of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Mar

AMAG

Amag Pharmaceuticals

$15.83

-0.19 (-1.19%)

12:45
02/20/19
02/20
12:45
02/20/19
12:45
Conference/Events
Amag Pharmaceuticals has a conference call hosted by JPMorgan »

JPMorgan Analyst Fye will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 27

    Feb

  • 23

    Mar

INST

Instructure

$40.82

-1.75 (-4.11%)

12:44
02/20/19
02/20
12:44
02/20/19
12:44
Recommendations
Instructure analyst commentary  »

Instructure's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

ACET

Aceto

$0.42

-0.625 (-59.81%)

12:41
02/20/19
02/20
12:41
02/20/19
12:41
Hot Stocks
Aceto receives Nasdaq notice due to delay in filing Form 10-Q »

Aceto Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSM

TSMC

$39.24

0.77 (2.00%)

12:40
02/20/19
02/20
12:40
02/20/19
12:40
Options
Taiwan Semi sees opening put buying »

Taiwan Semi sees opening…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HMHC

Houghton Mifflin

$8.94

0.52 (6.18%)

12:37
02/20/19
02/20
12:37
02/20/19
12:37
Hot Stocks
Houghton Mifflin Harcourt launches HMH Audio in-house audio production studio »

Houghton Mifflin Harcourt…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 28

    Feb

EA

Electronic Arts

$99.25

-3.73 (-3.62%)

, ATVI

Activision Blizzard

$43.82

-0.66 (-1.48%)

12:35
02/20/19
02/20
12:35
02/20/19
12:35
On The Fly
Game On: An exclusive talk with Beamdog CEO Trent Oster »

'NEVERWINTER NIGHTS'…

EA

Electronic Arts

$99.25

-3.73 (-3.62%)

ATVI

Activision Blizzard

$43.82

-0.66 (-1.48%)

TTWO

Take-Two

$89.77

-3.52 (-3.77%)

NTDOY

Nintendo

$0.00

(0.00%)

MSFT

Microsoft

$106.99

-0.77 (-0.71%)

SNE

Sony

$46.86

0.65 (1.41%)

TCEHY

Tencent

$0.00

(0.00%)

UBSFY

Ubisoft

$0.00

(0.00%)

CCOEY

Capcom

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 03

    Mar

  • 04

    Mar

  • 04

    Mar

  • 06

    Mar

  • 07

    Mar

  • 12

    Mar

  • 13

    Mar

  • 18

    Mar

12:35
02/20/19
02/20
12:35
02/20/19
12:35
General news
FOMC minutes preview: the minutes will be scrutinized »

FOMC minutes preview: the…

OSPN

OneSpan

$20.13

3.355 (20.00%)

12:33
02/20/19
02/20
12:33
02/20/19
12:33
Downgrade
OneSpan rating change  »

Imperial downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 12

    Mar

  • 28

    Mar

OSPN

OneSpan

$20.21

3.435 (20.48%)

12:28
02/20/19
02/20
12:28
02/20/19
12:28
Downgrade
OneSpan rating change  »

OneSpan downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 12

    Mar

  • 28

    Mar

KMI

Kinder Morgan

$19.20

0.05 (0.26%)

12:27
02/20/19
02/20
12:27
02/20/19
12:27
Hot Stocks
Kinder Morgan Chairman Richard Kinder buys over 19K shares of company stock »

Kinder Morgan Chairman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

NYT

New York Times

$32.02

0.06 (0.19%)

12:25
02/20/19
02/20
12:25
02/20/19
12:25
Hot Stocks
New York Times publisher responds to Trump's 'enemy of the people' tweet »

After President Trump…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

RTTR

Ritter Pharmaceuticals

$0.66

-0.0104 (-1.55%)

12:25
02/20/19
02/20
12:25
02/20/19
12:25
Conference/Events
Ritter Pharmaceuticals to host conference call »

Expert call with Dr Chey,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ZNGA

Zynga

$5.09

-0.01 (-0.20%)

12:20
02/20/19
02/20
12:20
02/20/19
12:20
Options
Defensive option play in Zynga as shares ease off 52-week highs »

Defensive option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

  • 25

    Feb

  • 11

    Mar

  • 11

    Mar

HSY

Hershey

$109.97

0.275 (0.25%)

12:19
02/20/19
02/20
12:19
02/20/19
12:19
Earnings
Hershey issues long-term adjusted EPS growth target of 6%-8% »

Hershey in conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 03

    Mar

MCS

Marcus

$40.59

1 (2.53%)

12:18
02/20/19
02/20
12:18
02/20/19
12:18
Hot Stocks
Marcus raises quarterly dividend 6.7% to 16c per share »

Directors of The Marcus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 02

    Apr

  • 02

    Apr

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.